Abstract
A 5-year-old boy with a known diagnosis of tuberous sclerosis complex was found to have an enlarging renal mass on routine ultrasound. He was diagnosed with an angiomyolipoma (AML) and scheduled for close observation. Follow-up magnetic resonance imaging demonstrated the AML to be significantly enlarged and hypervascular. Selective arterial embolization of the tumor was performed, which resulted in an appropriate decrease in tumor size. Angiomyolipoma is a known and well-described complication of the tuberous sclerosis complex that is usually found among patients in their adolescent and adult years. The case presented here illustrates the need for early and repeated renal imaging of younger pediatric patients with tuberous sclerosis. Our experience adds to the literature on young pediatric patients requiring embolization for treatment of large renal angiomyolipomas.
This is a preview of subscription content, log in via an institution to check access.
Abbreviations
- AML:
-
angiomyolipoma
- ESRD:
-
end-stage renal disease
- RCC:
-
renal cell carcinoma
- SAE:
-
selective arterial embolization
- TSC:
-
tuberous sclerosis complex
References
Curatolo P (2003) Tuberous sclerosis complex: from basic science to clinical phenotypes. Mack Keith Press, London
Bissada NK, Smith PL, White HJ, Barbour GL, Sun CN, Redman JF (1975) Tuberous Sclerosis complex and renal angiomyolipoma. Urology 6:105–113
Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES (1988) Renal lesion growth in children with tuberous sclerosis complex. J Urol 160:140–145
Nelson CP, Sanda MG (2002) Contemporary diagnosis and management of renal angiomyolipoma. J Urol 168:1315–1325
Shepherd CW, Gomez MR, Lie JT, Crowson CS (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 6:792–796
Bissler JJ, Kingswood JC (2004) Renal angiomyolipomata. Kidney Int 66:924–934
Cook JA, Oliver K, Mueller RF, Sampson J (1996) A cross sectional study of renal involvement in tuberous sclerosis. J Med Genet 33:480–484
O’Callaghan FJ, Noakes MJ, Martyn CN, Osborne JP (2004) An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int 94:853–857
Stillwell TJ, Gomez MR, Kelalis P (1987) Renal lesions in tuberous sclerosis. J Urol 138:477–481
Kandt RS, Haines JL, Smith M, Northrup H, Gardner RJM, Short MP, Dumars K, Roach ES, Steingold S, Wall S, Blanton SH, Flodman P, Kwiatkowski DJ, Jewell A, Weber JL, Roses AD, Pericak-Vance MA (1992) Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 2:37–41
Steiner MS, Goldman SM, Fishman EK, Marshall FF (1993) The natural history of renal angiomyolipoma. J Urol 150:1782–1786
Lendvay TS, Marshall FF (2003) The tuberous sclerosis complex and its highly variable manifestations. J Urol 169:1635–1642
Oesterling JE, Fishman EK, Goldman SM, Marshall FF (1986) The management of renal angiomyolipoma. J Urol 135:1121–1124
Uhlenbrock D, Fischer C, Beyer HK (1988) Angiomyolipoma of the kidney: comparison between magnetic resonance imaging, computed tomography, and ultrasonography for diagnosis. Acta Radiol 29:523–526
O’Hagan AR, Ellsworth R, Secic M, Rothner AD, Brouchard BH (1996) Renal manifestations of tuberous sclerosis complex. Clin Pediatr 35:483–489
El-Hashemite N, Zhang H, Henske EP, Kwiatowski DJ (2003) Mutation in TSC2 and activation of mammalian target of rapamycin signaling pathway in renal angiomyolipoma. Lancet 361:1348–1349
Niida Y, Stemmer-Rachamimov AO, Logrip M, Tapon D, Perez R, Kwiatkowski DJ, Sims K, MacCollin M, Louis DN, Ramesh V (2001) Somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet 69:493–503
Tchaprassian A, Mognato G, Paradias G, D’Amore ESG, Tregnaghi A, Cecchetti G (1998) Renal angiomyolipoma in children: diagnostic difficulty in 3 patients. J Urol 159:1654–1656
Kothary N, Soulen MC, Clark TWI, Wein AJ, Shlansky-Goldberg RD, Crino PB, Stavropoulos SW (2005) Renal angiomyolipoma: long term results after arterial embolization. J Vasc Interv Radiol 16:45–50
Patel U, Simpson E, Kingswood JC, Saggar-Malik AK (2005) Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma. Clin Radiol 60:665–673
Harabayashi T, Shinohara N, Katano H, Nonomura K, Shimizu T, Koyanagi T (2004) Management of renal angiomyolipomas associated with tuberous sclerosis complex. J Urol 171:102–105
Bissler JJ, Racadio J, Donnelly LF, Johnson ND (2002) Reduction of postembolization syndrome after ablation of renal angiomyolipoma. Am J Kidney Dis 39:966–971
Earthman WJ, Mazer MJ, Winfield AC (1986) Angiomyolipomas in tuberous sclerosis: subselective embolotherapy with alcohol, with long-term follow-up study. Radiology 160:437–441
Kenerson H, Dundon TA, Yeung RS (2005) Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res 57:67–75
Kenerson HL, Aicher LD, True LD, Yeung RS (2002) Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res 62:5645–5650
Casper KA, Donnelly LF, Chen B, Bissler JJ (2002) Tuberous sclerosis complex: renal imaging findings. Radiology 225:451–456
Hyman MH, Whittemore VH (2000) National Institutes of Health consensus conference: tuberous sclerosis complex. Arch Neurol 57:662–665
Acknowledgements
This study was made possible by the support of the Carol and James Herscot Center for Tuberous Sclerosis Complex.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Winterkorn, E.B., Daouk, G.H., Anupindi, S. et al. Tuberous sclerosis complex and renal angiomyolipoma: case report and review of the literature. Pediatr Nephrol 21, 1189–1193 (2006). https://doi.org/10.1007/s00467-006-0133-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0133-3